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Mortality associated with delay in operation after hip fracture
Scottish data provide additional
information . . .
Editor—Bottle and Aylin’s study provides
evidence of an association between delay to
hip fracture surgery and mortality,1 a topic
that has proved controversial.2 However, as
their analysis depended on routinely col-
lected data, the study had important
limitations. Scottish data provide additional
relevant information.
Scottish hip fracture audit data are
collected prospectively,3 and records have
been linked to routinely collected data for
hospital admissions and mortality.4 We
studied one year mortality in patients
undergoing hip fracture surgery between
1998 and 2003, in groups of patients strati-
fied by the reason for delay to surgery
(n = 8470). We used Cox proportional
hazards regression analysis to adjust for
potential confounding factors including
age, sex, hospital, and residence before the
fracture; American Society of Anesthesiolo-
gists’ grade (a measure of systemic illness
before fracture); and number and type of
hospital admissions in the five years before
the hip fracture.
Surgery was delayed by more than 24
hours after hospital admission in 3364
(40%) patients, of which 1432 operations
(43%) were delayed for administrative
reasons including restricted access to thea-
tre, surgeon, or anaesthetist; 1315 people
(39%) were initially medically unfit for
surgery and 617 operations (18%) were
delayed for other reasons. Overall, 2531
(30%) patients died in the year after
admission for hip fracture. Compared with
patients operated on within 24 hours, delay
to surgery in patients who were initially
medically unfit was associated with
increased mortality (hazard ratio 1.3; 95%
confidence interval 1.1 to 1.4). However,
there was no evidence of an association
between delay to surgery and mortality for
patients whose operation was delayed for
administrative reasons (hazard ratio 0.9,
95% confidence interval 0.8 to 1.0) or for
other reasons (1.1, 0.9 to 1.2).
These Scottish data support an associa-
tion between delay to surgery and mortality
after hip fracture, and show that the
association persisted for at least a year after
admission for hip fracture. However, the
excess mortality seems only to be present
when the delay was for medical reasons. The
importance of delay to hip fracture surgery
therefore remains open to debate.
D Graham Mackenzie specialist registrar in public
health
Public Health Department, NHS Fife, Cameron
House, Cameron Bridge, Windygates, Leven
KY8 5RG
gm@nhs.net
Sarah Wild senior lecturer in public health and
epidemiology
School of Clinical Sciences and Community
Health, University of Edinburgh, Edinburgh
EH8 9AG
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. . . but Italian data seem to contradict
study findings
Editor—In contrast to Bottle and Aylin,1 we
found that delayed surgery alone seems not
to increase mortality after hip fracture after
adjustment for comorbidity, age and sex,
and taking hospital level variability into
account.
We examined data from regional
hospital discharge registers in Friuli Ven-
ezia Giulia, a region in northeastern Italy
(population 1 200 000), where each year
more than 2200 elderly people are admit-
ted for hip fracture. We selected all patients
aged 65 and older with a main diagnosis of
hip fracture that was surgically treated dur-
ing 1996-2005, excluding patients with
malignant neoplasm. In cases of multiple
hip fracture we included only the first
episode.
We considered all diagnoses coded in
the hospital discharge records and in those
of the previous year, calculating the Charl-
son comorbidity index for each patient2 and
dichotomising it such that 1 indicated
presence of comorbidity and 0 absence. We
dichotomised the waiting time for surgery
by following the clinical indication in the
medical literature (1 indicated immediate
surgical treatment (same day or one day
after admission) and 2 delayed surgical
treatment (two days or more after admis-
sion)). We included the year in which the
fracture occurred in the multivariate models
to evaluate changing trends in mortality,
after controlling for case mix of patients, and
modelled this as a continuous variable. We
estimated non-conditional logistic regres-
sion models and several multilevel logistical
models to take into account hospital level
variability.3–5 We used a logistic regression
model with robust variance estimates
(Hubner/White/sandwich estimator) speci-
fying hospitals as a cluster variable to obtain
confidence intervals for the odds ratio
adjusted for intraclass correlation. Confi-
dence intervals were provided. We used
Stata 7.0 for analysis.
In all, 13 822 patients were included,
4.7% of them dying in hospital. Bivariate
analysis showed a significant association
between mortality and age, male sex, comor-
bidity, and delayed surgery and a decrease in
mortality from 1996 to 2005. Multilevel
models showed no significant association
between delayed surgery and increasing
in-hospital mortality (odds ratio 1.18, 95%
confidence interval 0.84 to 1.65). Comorbid-
ity, male sex, and advanced age were associ-
ated with increased mortality in hospital and
after discharge in all estimated models.
Between 1996 and 2005 mortality decreased
significantly.
Antonella Franzo epidemiologist
antonella.franzo@sanita.fvg.it
Giorgio Simon epidemiologist
Carlo Francescutti epidemiologist
Agenzia Regionale della Sanità, piazzale Santa
Maria della Misericordia 15, 33100 Udine, Italy
Competing interests: None declared.
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Panic disorder: propranolol
and behavioural therapy
Editor—Barr Taylor clearly shows that selec-
tive serotonin reuptake inhibitors (SSRIs) are
well accepted as first line treatment for panic
disorder.1 However, many patients are still
prescribed propranolol along with diazepam
as first line treatment in primary care trusts to
treat the adrenergic symptoms of panic
disorder—such as palpitations, etc—although
 blockers have no proved efficacy in the
treatment of panic disorder.
Considering patients’ choice of treat-
ments, many patients are generally quite
keen on non-pharmacological methods
such as cognitive behaviour therapy, espe-
cially after they consider the side effect pro-
file of SSRIs. But if we consider the cost
implications, one year’s treatment with an
SSRI—for example, paroxetine 20 mg—costs
an estimated £289, including direct and
indirect prescribing and including follow-up
costs, which is around £10 more or less than
other generic drugs. However, 16 one hour
sessions of cognitive behaviour therapy
delivered by a clinical psychologist cost an
estimated £1056. That is more than £300
extra expenditure per patient per year.2 In
addition, the waiting lists of psychology
departments are sometimes long.
Thus it is yet to be answered which is the
most cost effective treatment for panic
disorder, and only more thorough ran-
domised controlled trials with patients
receiving SSRIs and cognitive behaviour
therapy can answer that.
Manjeestha Das senior house officer in psychiatry
NHS Grampian, Dr Gray’s Hospital, Elgin, Moray
IV30 1SN
m.das@nhs.net
Competing interests: None declared.
1 Barr Taylor C. Panic disorder. BMJ 2006;332:951-5. (22
April.)
2 National Institute for Health and Clinical Excellence.
NICE guidance on management of obsessive compulsive
disorder. Draft for second consultation, May 2005:231.
Preterm delivery in
primiparous women at low risk
Preterm birth or delivery? Study authors
suggest new terms
Editor—The term preterm birth is used dif-
ferently in the literature: some use preterm
birth to refer to the number of infants born
before 37 completed weeks,1 2 and others
use the term to specify the number of preg-
nancies ending before 37 completed weeks.3
Still others have restricted their analyses to
singleton pregnancies to avoid this differ-
ence.4 The use of the alternative term
preterm delivery varies in a similar fashion.
We noticed this difference in our study
looking at infants born preterm and preg-
nancies ending preterm in Danish national
data from 1995-2004 (22 April, pp 937-9).We
found that the national proportion of
preterm infants rose from 5.8% (4019/
69 013) in 1995 to 7.2% (4650/64 223) in
2004; an increase of 24%. However, when
mothers or pregnancies were counted, the
proportions were 5.2% (3509/67 840) in
1995 and 6.3% (3975/62 814) in 2004, an
increase of 22%. This discrepancy can easily
be explained, as the proportion of twin gesta-
tions rose from 1.7% to 2.3% of all gestations
during this 10 year period.
We often asked ourselves: “Does a twin
pregnancy that ends at 32 weeks count as
one or two preterm births?” From the obste-
trician’s point of view this is most likely to be
one preterm birth but from a paediatric
point of view, two. The quality of the data
collected for many national registers and
studies makes it possible to make this
distinction. To compare such data over time,
as well as between populations, it is
important that agreement on the definitions
of these terms be reached, especially at a
time when the proportion of twin pregnan-
cies is increasing. The importance of identi-
cal international definitions in perinatal
health is a precondition for evaluation of
differences in outcomes between popula-
tions and has already been recognised in the
PERISTAT project.5
We therefore propose two different, new,
and distinguishable definitions: a preterm
ending pregnancy ends before 37 com-
pleted weeks, and a preterm born infant is
born before 37 completed weeks. A twin
pregnancy delivered at 32 weeks will
therefore be counted as one preterm ending
pregnancy but as two preterm born infants.
Ida Vogel associate professor
Department of Clinical Genetics, Aarhus University
Hospital, DK-8000 Aarhus, Denmark
iv@soci.au.dk
Ulrik Kesmodel associate professor
NANEA at the Institute of Public Health,
Department of Epidemiology, University of Aarhus,
DK-8000 Aarhus
Steen Rasmussen statistician
National Board of Health, Health Statistics,
DK-2300 Copenhagen, Denmark
Jens Langhoff-Roos consultant
Juliane Marie Centre, Department of Obstetrics,
Rigshospitalet, DK-2100 Copenhagen
Bo Jacobsson associate professor
Perinatal Centre, Department of Obstetrics and
Gynecology, Sahlgrenska University
Hospital/Ostra, SE-41345 Gothenburg, Sweden
Competing interests: None declared.
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smoking. Acta Obstet Gynecol Scand 2005;84:558-65.
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Indicators of fetal and infant health outcomes. Eur J Obstet
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Could epidemic chlamydia contribute to
rise in preterm births?
Editor—The rise in preterm births
described in Denmark would give cause for
concern, in terms of long term health conse-
quences, in any country.1 One risk factor that
is not described in this study is infection with
chlamydia,2 which is rising rapidly among
young women in urban areas of the United
Kingdom.
Given that most affected patients are
unaware of their infection, and that specialist
screening and treatment facilities are not eas-
ily accessible for most populations, could this
be the “invisible” factor driving higher rates of
premature babies, among “low risk”mothers?
Woody Caan professor of public health
Anglia Ruskin University, Chelmsford CM1 1SQ
a.w.caan@anglia.ac.uk
Competing interests: WC is supervising a
community research project on chlamydia.
1 Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S,
Vogel I. Spontaneous preterm delivery in primiparous
women at low risk in Denmark: population based study.
BMJ 2006;332:937-9. (22 April.)
2 Caan W. Implications for the economic evaluation of other
screening programmes eg for chlamydia [electronic
response to Kiss et al. Prospective randomised controlled
trial of an infection screening programme to reduce the
rate of preterm delivery]. http://bmj.bmjjournals.com/
cgi/eletters/329/7462/371[69924 (5 August 2004).
Is any involvement with the UK
military unethical?
Editor—There are good ethical arguments
for UK military staff to now refuse to partici-
pate in the military involvement in Iraq, as
highlighted by the case of Kendall-Smith.1
But are theremajor ethical problems with any
association with the British military? Its
possession of nuclear weapons and its failure
to make substantive progress phasing these
out,2 despite disarmament being legally
required by Article VI of the Nuclear
Non-Proliferation Treaty (NPT), begs this
question. Such a requirement has also been
reinforced by the International Court of
Justice ruling on the illegality of using nuclear
weapons. Indeed, there are concerns that
rather than disarming, the UK primeminister
favours building a new generation of nuclear
weapons to replace the Trident system.3
The Mutual Defence Agreement (MDA)
between the United States and the United
Kingdom can be considered to support
nuclear proliferation by facilitating UK
weapons development. Furthermore, a legal
opinion from respected UK lawyers has
concluded that: “In our view, it is strongly
arguable that the renewal of the MDA is in
breach of the NPT.”4
With the world facing such critical issues
such as climate change, environmental dam-
age, and poverty, are the huge sums involved
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in nuclear military expenditure also unethi-
cal? For nuclear weapons this resource use is
massive with the UK government recently
announcing it intends to spend more than
£1 billion during the next three years to
ensure the continued reliability of the exist-
ing Trident warhead stockpile.2
For these reasons, health workers with
any links to the UK military (and indeed all
military staff) should question their associa-
tion from an ethical perspective. Health pro-
fessional organisations should also consider
isolating nuclear capable militaries in the
same way they have worked to isolate other
industries that cause widespread harm, such
as the tobacco industry.
Nick Wilson public health physician
IPPNW, PO Box 1702, Wellington, New Zealand
nwilson@actrix.gen.nz
Competing interests: NW is chair of the New
Zealand Affiliate of the International Physicians
for the Prevention of Nuclear War (IPPNW).
1 Dyer O.Air force doctor imprisoned for refusing third tour
in Iraq. BMJ 2006;332:931. (22 April.)
2 Norris RS, Kristensen HM. British nuclear forces, 2005.
Bulletin of the Atomic Scientists 2005;61:77-9.
www.thebulletin.org/article_nn.php?art_ofn = nd05norris
(accessed 27 April 2006).
3 Thompson M, Lewis J. A new generation of nuclear
weapons? Guardian 2005, July 4:20. http://politics.
guardian.co.uk/foreignaffairs/comment/
0,11538,1520673,00.html (accessed 27 April 2006).
4 Singh R, Chinkin C. Mutual Defence Agreement and the
Nuclear Non-Proliferation Treaty: joint advice. BASIC, the
Acronym Institute for Disarmament Diplomacy and
Peacerights. 2004. www.basicint.org/nuclear/
MDAlegal.htm (accessed 27 April 2006).
Compensation and complaints
in New Zealand
Editor—In New Zealand complaints about
quality of care are resolved independently
from claims for compensation. The New
Zealand Health and Disability Commis-
sioner does not serve as a “gateway” to the
no-fault compensation system.1
For 30 years New Zealand has essentially
barred medical malpractice litigation. All
patients who have a treatment injury are eli-
gible to receive government funded com-
pensation through the Accident Compensa-
tion Corporation. After reforms in 2005 the
scheme is truly no-fault with no requirement
to establish any error or negligence on the
part of the healthcare provider.2
Separate and independent processes are
available for responding to patients’ non-
monetary interests (such as the desire for an
apology, an explanation, or corrective action
to prevent harm to future patients).3 In par-
ticular, the Health and Disability Commis-
sioner resolves complaints by advocacy,
investigation, or mediation.4
The commissioner’s focus is on opening
channels of communication between the
doctor and patient, understanding what went
wrong and why, and supporting doctors and
healthcare organisations back into safe
practice. The process is confidential, though
the commissioner’s findings are widely dis-
seminated in an anonymised form so that les-
sons can be learnt from the adverse event.
Of course, some injured patients seek
monetary and non-monetary remedies and
may choose both to lodge a complaint and
to file a no-fault compensation claim.
Marie M Bismark senior solicitor
Buddle Findlay, 1 Willis Street, PO Box 2694,
Wellington 6001, New Zealand
mariebismark@gmail.com
Competing interests: None declared.
1 Marcovitch H. Patents’ complaints are “tip of an iceberg” in
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2 Bismark MM, Paterson RJ. No-fault compensation in New
Zealand: harmonizing injury compensation, provider
accountability, and patient safety. Health Affairs
2006;25:278-83.
3 Bismark MM, Dauer EA. Motivations for medico-legal
action: lessons from New Zealand. Journal of Legal Medicine
2006;27:55-70.
4 Paterson RJ. The patients’ complaints system in New Zea-
land. Health Affairs 2002;21(3).
Policing of information from
internet breast cancer list
Findings may not be generally applicable
Editor—The article by Esquivel et al is
misleading in some respects.1 Their findings
result from internet correspondence between
individuals about a common condition that is
given a lot of webspace and media attention.
My own (anecdotal) experience shows
that a vast amount of ignorance remains
when rarer conditions are considered.
Between 2001 and 2003 I attempted to
recruit women with hypoadrenalism for a
study looking into adrenal hormone
replacement. As this condition is very rare, I
resorted to advertising for subjects on two
websites, those of self help groups for
hypoadrenalism (after this had been
approved by the ethics committee).
I managed to recruit sufficient numbers
for the study but kept myself enrolled to
check on progress among my volunteers
until mid-2005. I was surprised to see the
depth of inaccuracy and distinct lack of
knowledge among the people who posted
on the sites. I refused to be drawn into
discussions, as I would have ended up being
the group doctor, which I had no intention
of becoming. The one person on those sites
who seemed to be giving the most informa-
tion was a laboratory technician whose wife
had hypoadrenalism.
Furthermore, from personal experience
and that of my colleagues, the ever
increasing band of “informed” patients who
come to clinic armed with items they “found
on the web,” that vary from wildly inaccurate
to frankly amusing, shows that many people
refer to the web, but that an awful lot of non-
sense is to be found there.
I have no problem with tackling the fears
and questions of concerned patients, but
when having to contradict the perceived
wisdom of the all powerful internet, I
wonder whether this is yet another reason to
consider early retirement.
Ketan K Dhatariya consultant endocrinologist
Norfolk and Norwich University Hospital NHS
Trust, Norwich, Norfolk, NR4 7UY
ketan.dhatariya@nnuh.nhs.uk
Competing interests: None declared.
1 Esquivel A, Meric-Bernstam F, Bernstam EV. Accuracy and
self correction of information received from an internet
breast cancer list: content analysis. BMJ 2006;332:939-42.
(22 April.)
“List mining” raises new issues in
research ethics
Editor—“List mining” can be defined as the
use, for research purposes, of messages sent
to internet based mailing lists. The ethical
questions raised by list mining are especially
important for health related lists. For
example:
x Should the people who were the original
sources of messages sent to such lists
properly be regarded as “research subjects”?
This perspective raises questions pertaining
to privacy, informed consent, whether the
research is intrusive and has potential for
harm, and whether the list should be
perceived as “private” or “public” space
x Should they be regarded as “published
authors”? Although most participants may
not even regard themselves as “amateur
authors,” issues of copyright and proper
attribution are to be considered if messages
sent to such lists are cited verbatim
x Should they be regarded as “members of
a community”? If so, how best to deal with
individuals in such communities whose
messages may need to be examined critically
because they might endanger public health?
Fortunately, the article by Esquivel et al pro-
vides evidence that, on the breast cancer
mailing list, self policing works.1
Relevant references about internet
research ethics are available.2
James E Till professor emeritus
University of Toronto, Toronto, Canada M5S 1A1
till@uhnres.utoronto.ca
Competing interests: None declared.
1 Esquivel A, Meric-Bernstam F, Bernstam EV. Accuracy and
self correction of information received from an internet
breast cancer list: content analysis. BMJ 2006;332:939-42.
(22 April.)
2 Internet research ethics. Wikipedia. The free encyclopedia
http://en.wikipedia.org/wiki/Internet_research_ethics
(accessed 26 Apr 2006).
The cause for quiet celebration
Editor—Perhaps we can help put Robert
Jacoby and the dozen other men who found
our editorial distressing out of at least a little
of their misery?1 2
The reason for the quiet celebration we
suggest is that it has generally only been in
extremely poor countries that women have
died earlier than men in recent decades. By
2006 almost nowhere in the world seems so
absolutely poor (at least in this sense) that
this continues to be the case.
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We perhaps should have been clearer in
what we wrote—but then no woman seems to
have misunderstood the cause for quiet
celebration, at least none who has responded
to the editorial. Whether the United States
has a “federally funded Office of Women’s
Health” (which seems to exercise Jacoby) is
immaterial as to whether slightly fewer
women in the poorest countries in the world
now die than used to, often while delivering
their (and their partner’s) baby.
Anna Barford research fellow
Danny Dorling professor of human geography
Danny.Dorling@sheffield.ac.uk
Department of Geography, University of Sheffield,
Sheffield S10 2TN
George Davey Smith professor of clinical
epidemiology
Mary Shaw reader in medical sociology
Department of Social Medicine, University of
Bristol, Bristol BS8 2PR
Competing interests: None declared.
1 Jacoby RA. A sexist celebration. BMJ 2006;332:976. (22
April.)
2 Barford A, Dorling D, Davey Smith G, Shaw M. Life
expectancy: women now on top everywhere. BMJ
2006;332: 808. (8 April.)
Boom to bust in the NHS
Income in general practice
Editor—Maynard and Street state that gen-
eral practitioners have received a pay rise
and are receiving “fees per service for
targeted care of chronically ill patients.”1
In fact, general practitioners have
received a reduction in pay in real terms. The
minimum practice income guarantee has
been frozen for three years running, resulting
in a reduction in pay of 10% in real terms.
The only new money is for collecting data
for the quality and outcomes framework,
which is not fee for service but performance
related pay. This work is unambiguously new
and is in addition to the requirements for
providing general medical services. Income
generated by performing these new tasks has
hidden the underlying pay cut.
Headline increases in practice income are
misleading as the responsibility for funding
the employer’s contribution for pensions has
been transferred to the contractors.
The pay rate of £90 per hour quoted for
out of hours by the authors is equivalent to
about £37 per hour for daytime services
provided (agenda for change levy of 50% for
unsociable hours, 14% reduction for
employer’s pension payment, 15% reduction
for holiday and study leave entitlements,
10% reduction for insuring against loss of
earnings through illness, and 4% for indem-
nity). This (£37 per hour) may be excessive,
but is subject to market forces. Perhaps the
increasing cost of providing out of hours
care is caused by the loss of the substantial
subsidy general practitioners have given to
the service in the past.
Hendrik J Beerstecher principal general practitioner
111 Canterbury Road, Sittingbourne, Kent,
ME10 4JA
hendrick.beerstecher@nhs.net
Competing interests: HJB is an NHS general
practitioner.
1 Maynard A, Street A. Seven years of feast, seven years of
famine: boom to bust in the NHS? BMJ 2006;332:906-8.
(15 April.)
Consultant productivity
Editor—Over recent years consultants have
had to spend more and more time on things
that don’t increase productivity.1 Some of
these are worth while (such as talking to
patients), and some perhaps not (such as
satisfying the bureaucracies of appraisal,
continuing professional development,
research and development, and clinical gov-
ernance). Consultants are also doing things
previously done by junior staff. The new
contract was implemented without official-
dom recognising how much many consult-
ants were doing—and as trusts cannot pay
for the time required to do it, it’s no surprise
that the new contract has done little for con-
sultant productivity. If consultants are being
paid more for less, it’s partly because they
weren’t paid for much of what they did
under the old contract.
Edmund J Dunstan consultant geriatrician
Selly Oak Hospital, Birmingham B29 6JD
edmund.dunstan1@btinternet.com
Competing interests: EJD is an NHS consultant.
1 Maynard A, Street A. Seven years of feast, seven years of
famine: boom to bust in the NHS? BMJ 2006;332:906-8.
(15 April.)
Questions on productivity
Editor—Maynard and Street’s article raises
many questions.1
After the “feast” we have had so far, what
is the absolute spending on health relative to
gross domestic product? Is it still below
other top economic nations?
What is the productivity of other health
systems, and how have these changed
during 1998-2004?
Has productivity in fact improved?2
Why no mention of confidence interval
or sensitivity analysis for the change in pro-
ductivity?
Is the concept of instantaneous change in
productivity scientifically realistic? Genuine
healthcare outputs depend on biology, and
here the law of diminishing returns really
does have a solid basis. Change in productiv-
ity could thus at best follow a logistic curve.
One would also expect a substantial time
delay between change in input and any
changes in output to show through—for
example, increase in life expectancy from
better management of angina.
Ram Kumar paediatric neurology specialist registrar
Royal Manchester Children’s Hospital, Manchester
M27 4HA
ram16k@yahoo.com.au
Competing interests: RK is a doctor.
1 Maynard A, Street A. Seven years of feast, seven years of
famine: boom to bust in the NHS? BMJ 2006;332:906-8.
(15 April.)
2 Lee P. Public service productivity: health. London: Office of
National Statistics, 2006.
Money for nothing, and your
kicks for free
Editor—You know you’ve upset the profes-
sion when a local colleague stops you in the
car park to say you’ve got it wrong. I merely
suggested on a Scottish news programme
that the general practitioners’ pay rise was
excessive and divisive.
We have seen record spending on health
care—to catch up for years of the NHS
underfunding.1 We were the backward medi-
cal child of Europe, with our French,
German, and Italian cousins enjoying much
better health care. This of course was a com-
plete false premise—merely doing more
operations, having more specialists, and tak-
ing more medicines should not be confused
with quality—but that’s politics. More spend-
ing indeed runs the very real risk of
overdiagnosis and unnecessary interven-
tions. The NHS had for decades made the
best of its lot—poverty giving it clarity and
priority. We were well paid, with a generous
pension, and we worked hard. Grumbling
was a popular and enjoyable pastime.
Unfortunately, this government has
squandered its cash.Wasted on “bling-bling”
waiting list initiatives. A drug culture not
only accepted but promoted. Negotiators
impressed by the professional muscle and
hard street talk shelled out big money for
less work and no control over quality of care.
A right rock and roll swindle. Now many
trusts are in trouble, but wait until next year.
Their financial wheels lashed by a 60%
increase in quality point payments—the
iceberg looms, the band is practising, but the
lifeboats are missing.
Paying doctors more has no impact on
patient care and may reduce the incentive
for well paid professionals to do extra.We do
need more doctors and nurses, but paying
general practitioners £100 000 a year will
attract only candidates motivated by status
and financial gain.We need a return to some
old fashioned ideals. Become a doctor
because it’s important, it’s fulfilling, and it’s a
vocation. If lawyers, accountants, or even
footballers get paid more, does it matter?
Sorry for the offence caused to the pro-
fession by such a radical suggestion—see you
in the car park.
Des Spence general practitioner
Glasgow G20 9DR
destwo@yahoo.co.uk
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